MJNA
MEDICAL MARIJUANA INC
Latest price
As of Oct 30, 2026, 11:54 AM EDT · Market data by Massive
Market cap
—
Volume
20.3M
Previous close
$0.0002
Day range
$0.0001 – $0.0002
Listed
—
Coverage
33 articles
Price performance
Recent trading
Newsroom
Latest MJNA coverage
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
[ad_1] San Diego, CA – (NewMediaWire) – November 22, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter en
Medical Marijuana, Inc. Subsidiary HempMeds Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
[ad_1] San Diego, CA – (NewMediaWire) – October 20, 2022 – Medical Marijuana, Inc.(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today the accomplishments made through a success
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
[ad_1] San Diego, CA – (NewMediaWire) – August 18, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending Jun
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Health Secures Features in Top Brazil Lifestyle Publications
[ad_1] San Diego, CA – (NewMediaWire) – July 14, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has est
Medical Marijuana, Inc. Subsidiary HempMeds Collaborates With Leading Research Hospital in Argentina to Study the Efficiency of CBD for Adult Epilepsy
[ad_1] San Diego, CA – (NewMediaWire) – July 06, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® is collaborati
Medical Marijuana, Inc. Subsidiary Kannaway Hosts Regional Conference in South Africa
[ad_1] San Diego, CA – (NewMediaWire) – June 30, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® will be hostin
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies
[ad_1] San Diego, CA – (NewMediaWire) – May 26, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has launched its first pharmaceutical
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
[ad_1] San Diego, CA – (NewMediaWire) – May 23, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil was feat
Medical Marijuana, Inc. Subsidiary Kannaway Announces Positive Preliminary Results of Validcare CBD Safety Study
[ad_1] San Diego, CA – (NewMediaWire) – May 18, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has participate
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
[ad_1] San Diego, CA – (NewMediaWire) – May 19, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Exponential Growth; Receives Validation From Medical Community
[ad_1] SAN DIEGO, CA – (NewMediaWire) – April 21, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today growth milestones in its HempMeds® Brasil b
Medical Marijuana, Inc. Subsidiary Kannaway Celebrates Best Revenue Month in Company History for South Africa Division in March 2022
[ad_1] Africa’s cannabis industry is rapidly expanding, becoming one of the Company’s top international growth markets, and is projected to be a $7 billion market by 2023. Reach and Markets highlights that the South African cannabis/cannabidiol (CBD) market is expected to see a CAGR of 28.4% Between 2022 and 2026. “2022 has been a truly ...
Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives
[ad_1] SAN DIEGO, CA – (NewMediaWire) – April 07, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, is pleased to provide a corporate update on its pharmaceut
Medical Marijuana, Inc. Reports $34.1 Million in Revenue in 2021 Annual Financial and Operational Results Filing
[ad_1] SAN DIEGO, CA – (NewMediaWire) – April 01, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, today announced its financial results for the year ending D
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Sponsors First Brazilian Obesity Medicine Symposium
[ad_1] SAN DIEGO, CA – (NewMediaWire) – February 24, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil is s
Medical Marijuana, Inc. Promotes Chief Financial and Information Officer Todd Morrow to Company President
[ad_1] San Diego, CA – (NewMediaWire) – February 10, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that the Company’s Chief Financial and I
Medical Marijuana, Inc. Subsidiary Kannaway Celebrates New Milestone; Achieves Best Revenue Month in Company History for Japan Division in December 2021
[ad_1] SAN DIEGO, CA – (NewMediaWire) – January 04, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had i
Medical Marijuana, Inc. Subsidiary Kannaway Announces November 2021 as the Best Month in Company History for Japan Division
[ad_1] San Diego, CA – (NewMediaWire) – December 08, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® Japan had
Medical Marijuana, Inc. CEO Featured on Seeking Alpha's CEO Interviews Podcast
[ad_1] San Diego, CA – (NewMediaWire) – November 24, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its CEO Blake Schroeder was featured
Medical Marijuana, Inc. Subsidiary Kannaway(R) Appoints Direct Sales Veteran Lennon Ledbetter as Vice President of Sales
[ad_1] San Diego, CA – (NewMediaWire) – October 14, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Ka
Medical Marijuana, Inc. Subsidiary Kannaway Launches in Hong Kong
[ad_1] San Diego, CA – (NewMediaWire) – September 1, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway® h
Medical Marijuana, Inc. Subsidiary HempMeds Releases Broad-Spectrum CBD-Infused Gummies
[ad_1] San Diego, CA – (NewMediaWire) – July 22, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a
Medical Marijuana, Inc. Subsidiary HempMeds Applauds Mexico's Supreme Court for Decriminalizing Cannabis
[ad_1] San Diego, CA – (NewMediaWire) – July 01, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® applauds Mexic
Medical Marijuana, Inc. Subsidiary HempMeds Welcomes UFC Champion Raoni Barcelos as Brand Spokesperson
[ad_1] San Diego, CA – (NewMediaWire) – June 24, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary HempMeds® is ex
Medical Marijuana, Inc. Names New Chief Executive Officer
[ad_1] San Diego, CA – (NewMediaWire) – June 17, 2021 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”) announced today that it has appointed Blake Schroeder as Chairman of the Board and named him as Chief Executive Officer and President of the Company. Mr. Schroeder replaces Dr. Stuart Titus in those roles. Dr. Titus re
Medical Marijuana, Inc. Subsidiary Kannaway Enters CBG Market in Europe
[ad_1] San Diego, CA – (NewMediaWire) – December 10, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has officia
Medical Marijuana, Inc. Subsidiary Kannaway Enters CBN Market; Expands Cannabinoid Portfolio
[ad_1] San Diego, CA – (NewMediaWire) – October 29, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has officia
Medical Marijuana, Inc. Subsidiary HempMeds Co-CEO Featured in Reuters Discussing Future of Mexicos Cannabis Industry
[ad_1] San Diego, CA – (NewMediaWire) – October 08, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, the co-CEO of subsidia
Medical Marijuana, Inc. Investment Company AXIM Biotechnologies Files Patent for Worlds First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)
[ad_1] San Diego, CA – (NewMediaWire) – October 06, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechn
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Announces August 2020 as the Best Revenue Month in Company History
[ad_1] San Diego, CA – (NewMediaWire) – September 17, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil had
Medical Marijuana, Inc. Announces Production and Warehouse Facility Expansion; Adds State-of-the-Art Manufacturing Capability and Hemp License
[ad_1] Medical Marijuana, Inc. will produce, encapsulate and package 80 percent of all of its products, such as cannabidiol (CBD)-based topicals, liquids, capsules, and powders, in-house. “This was a strategic and important decision for us — to develop and utilize our resources to their greatest potential and find new ways to create value for our ...
Medical Marijuana, Inc. Announces Sales Operations Milestone; Sells More Than 1.6 Billion Milligrams of CBD
[ad_1] San Diego, CA – (NewMediaWire) – August 27, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a significant opera
Medical Marijuana, Inc. Subsidiary Kannaway(R) Welcomes Distinguished Sales and Marketing Expert Carolyn Dielmann Connolly as Brand Ambassador
[ad_1] San Diego, CA – (NewMediaWire) – July 30, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® welcomes Caroly